Man Group plc - EMERGENT BIOSOLUTIONS INC ownership

EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 340 filers reported holding EMERGENT BIOSOLUTIONS INC in Q1 2021. The put-call ratio across all filers is 1.60 and the average weighting 0.1%.

Quarter-by-quarter ownership
Man Group plc ownership history of EMERGENT BIOSOLUTIONS INC
ValueSharesWeighting
Q3 2023$489,063
-85.2%
143,842
-68.0%
0.00%
-80.0%
Q2 2023$3,307,169
-51.1%
449,955
-31.1%
0.01%
-58.3%
Q1 2023$6,768,789
-34.8%
653,358
-25.7%
0.02%
-35.1%
Q4 2022$10,386,281
-24.4%
879,448
+34.3%
0.04%
-42.2%
Q3 2022$13,743,000
+4.4%
654,719
+54.4%
0.06%
+14.3%
Q2 2022$13,162,000
+1352.8%
424,016
+1821.2%
0.06%
+1766.7%
Q1 2022$906,000
+20.6%
22,070
+47.1%
0.00%0.0%
Q3 2021$751,000
+38.6%
15,000
+74.4%
0.00%
+50.0%
Q2 2021$542,000
+36.5%
8,600
+101.1%
0.00%0.0%
Q1 2021$397,000
-90.2%
4,277
-90.5%
0.00%
-88.9%
Q4 2020$4,040,000
-77.0%
45,094
-73.5%
0.02%
-73.9%
Q3 2020$17,596,000
+160.8%
170,292
+99.6%
0.07%
+102.9%
Q2 2020$6,746,000
+332.4%
85,313
+216.4%
0.03%
+240.0%
Q1 2020$1,560,000
+46.5%
26,965
+32.3%
0.01%
+150.0%
Q3 2019$1,065,000
-75.9%
20,388
-77.7%
0.00%
-75.0%
Q2 2019$4,419,000
-80.9%
91,478
-80.0%
0.02%
-81.8%
Q1 2019$23,103,000
-31.6%
457,297
-19.7%
0.09%
-41.3%
Q4 2018$33,766,000
-11.7%
569,602
-1.9%
0.15%
+7.1%
Q3 2018$38,232,000
-9.3%
580,779
-30.4%
0.14%
-19.1%
Q2 2018$42,142,000
-3.3%
834,665
+0.9%
0.17%
-13.1%
Q1 2018$43,565,000827,4480.20%
Other shareholders
EMERGENT BIOSOLUTIONS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Zebra Capital Management LLC 22,111$908,0002.08%
Global Alpha Capital Management Ltd. 460,530$18,909,0001.62%
AIMZ Investment Advisors, LLC 70,625$2,900,0001.19%
Bridge City Capital, LLC 39,835$1,636,0000.76%
PALISADE CAPITAL MANAGEMENT, LP 560,409$23,010,0000.53%
EARNEST PARTNERS LLC 2,071,376$85,051,0000.50%
RICE HALL JAMES & ASSOCIATES, LLC 302,721$12,430,0000.50%
SummerHaven Investment Management, LLC 14,476$594,0000.34%
Ridgewood Investments LLC 10,004$411,0000.27%
AtonRa Partners 11,505$472,0000.26%
View complete list of EMERGENT BIOSOLUTIONS INC shareholders